NDC 70510-2322
RADICAVA ORS
Edaravone
RADICAVA ORS is a Kit in the Human Prescription Drug category. It is labeled and distributed by Mitsubishi Tanabe Pharma America, Inc.. The primary component is .
| Product ID | 70510-2322_26a8730f-518e-40d1-b695-536526c6a87b |
| NDC | 70510-2322 |
| Product Type | Human Prescription Drug |
| Proprietary Name | RADICAVA ORS |
| Generic Name | Edaravone |
| Dosage Form | Kit |
| Marketing Start Date | 2022-05-12 |
| Marketing Category | NDA / |
| Application Number | NDA215446 |
| Labeler Name | Mitsubishi Tanabe Pharma America, Inc. |
| Active Ingredient Strength | 0 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
Packaging
NDC 70510-2322-1
1 KIT in 1 CARTON (70510-2322-1) * 50 mL in 1 BOTTLE (70510-2324-1)
| Marketing Start Date | 2022-05-12 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Drug Details
NDC Crossover Matching brand name "RADICAVA ORS" or generic name "Edaravone"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 70510-2321 | RADICAVA ORS | EDARAVONE |
| 70510-2322 | RADICAVA ORS | EDARAVONE |
| 70510-2171 | RADICAVA | EDARAVONE |
| 70510-2172 | RADICAVA | edaravone |
Trademark Results [RADICAVA ORS]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 RADICAVA ORS 90594021 not registered Live/Pending |
Mitsubishi Tanabe Pharma Corporation 2021-03-22 |
 RADICAVA ORS 79298102 not registered Live/Pending |
Mitsubishi Tanabe Pharma Corporation 2020-09-15 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.